1616587-33-7

Basic information

• Product Name: 3-(azidomethyl)-6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazine
• Synonyms: 3-(azidomethyl)-6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazine
• CAS NO: 1616587-33-7
• Molecular Weight: 347.324
• Mol File: 1616587-33-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(azidomethyl)-6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(azidomethyl)-6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazine(1616587-33-7)
• EPA Substance Registry System: 3-(azidomethyl)-6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazine(1616587-33-7)

Safety Data

• Hazardous Substances Data: 1616587-33-7(Hazardous Substances Data)

Upstream product

• 1616587-31-5 (6-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)pyridazin-3-yl)methanol 
• 1011487-94-7 (6-chloropyridazin-3-yl)methanol 
• 1395282-24-2 2-(2,6-difluoro-4-((tetrahydro-2H-pyran-4-yl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 

Relevant articles and documents

ARYL-SUBSTITUTED FUSED BICYCLIC PYRIDAZINE COMPOUNDS

The present invention provides a compound of formula (I) as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula (I), and pharmaceutical compositions comprising such compounds.